Similarly, increasing NRF2 expression or promoting nuclear localization (by KEAP1 downregulation) rescues the loss of dopaminergic neurons, and improves locomotor performance in PD Drosophila models [72, 73]. This evidence concerns the gene NFE2L2 and Parkinson disease.